SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-002374
Filing Date
2014-05-14
Accepted
2014-05-14 17:28:07
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051414.htm 10-Q 798563
2 EXHIBIT 10.1 exh_101.htm EX-10.1 211387
3 EXHIBIT 31.1 exh_311.htm EX-31.1 15588
4 EXHIBIT 31.2 exh_312.htm EX-31.2 15807
5 EXHIBIT 32.1 exh_321.htm EX-32.1 6666
6 EXHIBIT 32.2 exh_322.htm EX-32.2 6844
13 logo.jpg GRAPHIC 2393
  Complete submission text file 0001171843-14-002374.txt   4618576

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tkmr-20140331.xml EX-101.INS 674899
8 XBRL TAXONOMY EXTENSION SCHEMA tkmr-20140331.xsd EX-101.SCH 36680
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tkmr-20140331_cal.xml EX-101.CAL 21553
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tkmr-20140331_def.xml EX-101.DEF 154689
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tkmr-20140331_lab.xml EX-101.LAB 247578
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tkmr-20140331_pre.xml EX-101.PRE 156541
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 14842710
SIC: 2834 Pharmaceutical Preparations